menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  • ReachMD Healthcare Image
    Medical News

    Optimal Timing Maximizes Paxlovid Benefits for Treating COVID-19

  • ReachMD Healthcare Image
    Medical News

    Catalonia Sees Over 50% Rise in Suicidal Behaviors Post-COVID

  • ReachMD Healthcare Image
    Medical News

    Bacteria in the Intestine That Change in Response to Inflammation Could Have an…

Programs

  • What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
    MinuteCE®

    What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?

    1.00 program credits
  • No effect on the primary endpoint with SGLT2i post-MI, but significant effect o…
    ACC Action Center

    No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations

  • Deep Learner: Building AI to Improve Cardiovascular Care
    Medical Industry Feature

    Deep Learner: Building AI to Improve Cardiovascular Care

  • Early aggressive lipid-lowering strategy with PCSK9 siRNA performs better than …
    ACC Action Center

    Early aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD

  • Inflammatory Pathways in Severe Asthma: Focus on Mucus Plugs
    Medical Industry Feature

    Inflammatory Pathways in Severe Asthma: Focus on Mucus Plugs

  • Addressing Treatment Gaps Among Patients with MDS-Associated Anemia
    Medical Industry Feature

    Addressing Treatment Gaps Among Patients with MDS-Associated Anemia

Clinical Practice

  • Stopping aspirin after 1 month DAPT in ACS patients after stenting
    ACC Action Center

    Stopping aspirin after 1 month DAPT in ACS patients after stenting

  • Self-assessment on statin eligibility without prescription using a web app
    ACC Action Center

    Self-assessment on statin eligibility without prescription using a web app

  • Managing AKI in ICU Trauma Patients: The Role of a Multidisciplinary Team
    Clinician's Roundtable

    Managing AKI in ICU Trauma Patients: The Role of a Multidisciplinary Team

  • Applying SDM to Personalize Treatment Discussions on Recurrence Risk Reduction …
    CME/CE

    Applying SDM to Personalize Treatment Discussions on Recurrence Risk Reduction in Patients with Early-Stage Melanoma

    0.25 credits
  • South Asians With IBD: Underrepresented and Underappreciated
    CME/CE

    South Asians With IBD: Underrepresented and Underappreciated

    0.25 credits
  • No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
    ACC Action Center

    No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI

Doctors Lounge

  • The Dynamic Practice: Exploring Locum Tenens Opportunities
    Spotlight on Locum Tenens

    The Dynamic Practice: Exploring Locum Tenens Opportunities

  • KOL Knockout™: Cancer Pain Management Edition
    CME/CE

    KOL Knockout™: Cancer Pain Management Edition

    1.50 credits
  • Let’s Rewind: Recognizing NAFLD/NASH in the Primary Care Clinic
    CME/CE

    Let’s Rewind: Recognizing NAFLD/NASH in the Primary Care Clinic

    0.25 credits
  • Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
    NeuroFrontiers

    Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment

  • Poster Pearl: Improved Sensitivity of a Multi-Analyte Early Detection Test Base…
    Project Oncology®

    Poster Pearl: Improved Sensitivity of a Multi-Analyte Early Detection Test Based on Mutation, Methylation, Aneuploidy, & Protein Biomarkers

  • Poster Pearl: Imaging-Based Localization for MCED Tests Yields Lower Diagnostic…
    Project Oncology®

    Poster Pearl: Imaging-Based Localization for MCED Tests Yields Lower Diagnostic Burden

CME

  • Pruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP
    CME/CE

    Pruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP

    0.25 credits
  • Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying
    CME/CE

    Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying

    0.25 credits
  • Navigating the Evolving Landscape: Advanced Decision-Making in ATTR-CM
    CME/CE Live Broadcast

    April 29, 2024

    09:00 PM - 10:30 PM ET

    Navigating the Evolving Landscape: Advanced Decision-Making in ATTR-CM

  • Extending Treatment Durability  With Next-Generation Neovascular AMD Therapies
    CME/CE

    Extending Treatment Durability With Next-Generation Neovascular AMD Therapies 

    0.50 credits
  • Advancing IgAN Care: Expert Strategies for Transformative Patient Outcomes
    CME/CE Meeting

    May 25, 2024

    13:45 - 14:45 CEST

    Advancing IgAN Care: Expert Strategies for Transformative Patient Outcomes

  • Efficacy Data for Bispecific Antibodies in RRMM
    MinuteCE®

    Efficacy Data for Bispecific Antibodies in RRMM

    1.00 program credits

Industry Feature

  • Mechanism of Disease: Immunoglobulin A Nephropathy
    Medical Industry Feature

    Mechanism of Disease: Immunoglobulin A Nephropathy

  • CMV Infection After Transplant: Who’s at Risk and How to Manage?
    Medical Industry Feature

    CMV Infection After Transplant: Who’s at Risk and How to Manage?

  • Advancements in Pretreated Metastatic Triple-Negative Breast Cancer
    Medical Industry Feature

    Advancements in Pretreated Metastatic Triple-Negative Breast Cancer

  • The Current Standard of Care and Unmet Need in Anemia of CKD
    Medical Industry Feature

    The Current Standard of Care and Unmet Need in Anemia of CKD

  • Prevalence and Burden of Anemia of CKD
    Medical Industry Feature

    Prevalence and Burden of Anemia of CKD

  • Empower Your Patients  With a Seizure Action Plan
    Medical Industry Feature

    Empower Your Patients With a Seizure Action Plan

Schedule24 Apr 2024